Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adults
INTRODUCTION The current study evaluated the relationship between habitual physical activity (PA) levels and brain amyloid beta (Aβ) over 15 years in a cohort of cognitively unimpaired older adults. METHODS PA and Aβ measures were collected over multiple timepoints from 731 cognitively unimpaired ol...
Gespeichert in:
Veröffentlicht in: | Alzheimer's & dementia 2024-02, Vol.20 (2), p.1350-1359 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | INTRODUCTION
The current study evaluated the relationship between habitual physical activity (PA) levels and brain amyloid beta (Aβ) over 15 years in a cohort of cognitively unimpaired older adults.
METHODS
PA and Aβ measures were collected over multiple timepoints from 731 cognitively unimpaired older adults participating in the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study of Aging. Regression modeling examined cross‐sectional and longitudinal relationships between PA and brain Aβ. Moderation analyses examined apolipoprotein E (APOE) ε4 carriage impact on the PA‐Aβ relationship.
RESULTS
PA was not associated with brain Aβ at baseline (β = –0.001, p = 0.72) or over time (β = –0.26, p = 0.24). APOE ε4 status did not moderate the PA‐Aβ relationship over time (β = 0.12, p = 0.73). Brain Aβ levels did not predict PA trajectory (β = –54.26, p = 0.59).
DISCUSSION
Our study did not identify a relationship between habitual PA and brain Aβ levels.
Highlights
Physical activity levels did not predict brain amyloid beta (Aβ) levels over time in cognitively unimpaired older adults (≥60 years of age).
Apolipoprotein E (APOE) ε4 carrier status did not moderate the physical activity–brain Aβ relationship over time.
Physical activity trajectories were not impacted by brain Aβ levels. |
---|---|
ISSN: | 1552-5260 1552-5279 1552-5279 |
DOI: | 10.1002/alz.13556 |